Nasrin Babadi, PhD, is the IND Specialist for the UNC Lineberger Comprehensive Cancer Center at the University of North Carolina Chapel Hill. In her role, she is responsible for providing regulatory guidance and support to Lineberger investigators relevant to their clinical research activities. Her responsibilities include development of regulatory strategies for trials in various therapeutic areas, including drugs, biologics, and devices. Additionally, Nasrin provides support to investigators and research teams in the coordination, implementation and management of sponsor activities to ensure ongoing compliance with federal regulations.
Nasrin received her undergraduate degree in Microbiology from the University of Oklahoma and completed her graduate studies at the University of Ottawa, where she received a PhD in Neuroscience. Following a year of postdoctoral research at Duke University, Nasrin joined UNC Lineberger, as part of the Clinical Protocol Office regulatory department. Additionally, Nasrin hold the US Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).
